Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / App Notes / 2022 / UHPLC analysis of cyclic peptides under LC/MS compatible conditions

UHPLC analysis of cyclic peptides under LC/MS compatible conditions

02/01/2022

Share

Featured Image

Cyclic peptides are characterised by polypeptide chains that are arranged in a cyclic ring structure. This structure offers various advantages over their linear counterparts: on the one hand cyclic peptides show a higher thermal stability and a higher resistance to digestion. On the other hand their rigid structure results in a better biological activity since the binding to the target molecule is improved. All these characteristics turn them into highly valuable drug candidates.

Cyclic peptides  have  various  applications; the peptides in this application note, polymyxin B sulfate, daptomycin and bacitracin are used as antibiotics for the treatment of bacterial infections, whereas cyclosporin  A  is  used  as  an  immunosuppressive agent.

>> Download the Application Note as a PDF

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Optimizing metal powders for Isostatic Pressing
Optimizing metal powders for Isostatic Pressing

January 4, 2022

Isostatic pressing has several benefits over the c...

Monitoring respirable silica at workplace
Monitoring respirable silica at workplace

January 5, 2022

Stringent regulations of occupational exposure to ...

Analytical toolkit for the optimization of battery electrode materials
Analytical toolkit for the optimization of battery electrode materials

January 7, 2022

Modern batteries like lithium-ion have revolutioni...

Analysis of catalytic ink for proton exchange membrane fuel cells (PEMFC’s)
Analysis of catalytic ink for proton exchange membrane fuel cells (PEMFC’s)

January 10, 2022

Catalytic inks are the key component when balancin...

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.